EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Lower Insulin Sensitivity Through 36 Months of Life With in Utero HIV and Antiretroviral Exposure in Botswana: Results From the Tshilo Dikotla Study

Jennifer Jao iD, Lauren B Bonner, Katrina Dobinda, Kathleen M Powis, Shan Sun, Justine Legbedze, Keolebogile N Mmasa, Joseph Makhema, Mompati Mmalane, Samuel Kgole, Gosego Masasa, Sikhulile Moyo und 5 weitere

Clinical Infectious Diseases · 26.09.2024 · 79 (3) · 727-733

DOI: 10.1093/cid/ciae088 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 26.03.2024. Verfasst von Jennifer Jao und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: HIV Infections, Insulin Resistance, Pregnancy Complications, Infectious, Anti-HIV Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Stable Isotope and Metabolomics Core Facility, NIGMS NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There are little data on changes in insulin sensitivity during the first few years of life following in utero human immunodeficiency virus (HIV) and antiretroviral (ARV) exposure.

Methods

The Tshilo Dikotla study enrolled pregnant persons with HIV (PWH) (receiving tenofovir/emtricitabine or lamivudine plus dolutegravir or efavirenz) and pregnant individuals without HIV, as well as their liveborn children. Newborns were randomized to receive either zidovudine (AZT) or nevirapine (NVP) postnatal prophylaxis. Homeostasis Model Assessment for Insulin Resistance (HOMA-IR) was assessed at birth and 1, 18, 24, and 36 months of life. We fit linear mixed-effects models to evaluate the association between in utero HIV/ARV exposure and average HOMA-IR from birth through 36 months of life, adjusting for confounders.

Results

A total of 419 children were included (287 with in utero HIV/ARV exposure and uninfected [CHEU] and 132 without in utero HIV/ARV exposure [CHUU]). CHEU were born to older women (29.6 vs 25.3 years of age) with higher gravidity (3 vs 1). HOMA-IR was persistently higher in CHEU versus CHUU in adjusted analyses (mean difference of 0.07 in log10 HOMA-IR, P = .02) from birth through 36 months of life. Among CHEU, no differences in HOMA-IR were observed from birth through 36 months by in utero ARV exposure status or between AZT and NVP infant prophylaxis arms.

Conclusions

In utero HIV/ARV exposure was associated with lower insulin sensitivity throughout the first 36 months of life, indicating persistent early life metabolic disturbances which may raise concern for poorer metabolic health later in life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsInsulin ResistancePregnancy Complications, InfectiousAnti-HIV AgentsHumansFemalePregnancyBotswanaInfantInfant, NewbornAdultMaleZidovudineChild, PreschoolCyclopropanesPrenatal Exposure Delayed EffectsInfectious Disease Transmission, VerticalEmtricitabineLamivudineAlkynesYoung AdultOxazinesBenzoxazinesNevirapine

Stichwörter der Autor:innen

homeostatic model assessmentin utero HIV exposureinsulin sensitivitymetabolicperinatal HIV exposure

Substanzen

Anti-HIV AgentsZidovudineCyclopropanesEmtricitabineLamivudineAlkynesefavirenzOxazinesBenzoxazinesNevirapine

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Pediatric Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Department of Pediatrics, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Botswana-Harvard Health Partnership, Gaborone, Botswana.
  • Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Departments of Internal Medicine and Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

ORCID-Profile: Jennifer Jao

Förderung

  • Stable Isotope and Metabolomics Core Facility
  • NIGMS NIH HHS
  • NIDDK NIH HHS
  • Albert Einstein College of Medicine
  • National Institute of General Medicine Sciences
  • Diabetes Research and Training Center
  • NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Jao, J., Bonner, L. B., Dobinda, K., Powis, K. M., Sun, S., Legbedze, J., Mmasa, K. N., Makhema, J., Mmalane, M., Kgole, S., Masasa, G., Moyo, S., Gerschenson, M., Mohammed, T., Abrams, E. J., Kurland, I. J., & Geffner, M. E. (2024). Lower Insulin Sensitivity Through 36 Months of Life With in Utero HIV and Antiretroviral Exposure in Botswana: Results From the Tshilo Dikotla Study. Clinical Infectious Diseases, 79(3), 727-733. https://doi.org/10.1093/cid/ciae088

Vancouver

Jao J, Bonner LB, Dobinda K, Powis KM, Sun S, Legbedze J, et al. Lower Insulin Sensitivity Through 36 Months of Life With in Utero HIV and Antiretroviral Exposure in Botswana: Results From the Tshilo Dikotla Study. Clinical Infectious Diseases. 2024;79(3):727-733. doi:10.1093/cid/ciae088

BibTeX
@article{Jao2024,
  author = {Jao, Jennifer and Bonner, Lauren B and Dobinda, Katrina and Powis, Kathleen M and Sun, Shan and Legbedze, Justine and Mmasa, Keolebogile N and Makhema, Joseph and Mmalane, Mompati and Kgole, Samuel and Masasa, Gosego and Moyo, Sikhulile and Gerschenson, Mariana and Mohammed, Terence and Abrams, Elaine J and Kurland, Irwin J and Geffner, Mitchell E},
  title = {Lower Insulin Sensitivity Through 36 Months of Life With in Utero HIV and Antiretroviral Exposure in Botswana: Results From the Tshilo Dikotla Study},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  volume = {79},
  number = {3},
  pages = {727--733},
  doi = {10.1093/cid/ciae088}
}
Kostenlos starten →